Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables

Overview

Journal Front Surg

Specialty General Surgery

Date 2017 May 31

PMID 28555187

Citations 18

Authors

Pavel Dulguerov

Jelena Todic

Marc Pusztaszeri

Naif H Alotaibi

Affiliations

Soon will be listed here.

Abstract

Background: The recurrence of pleomorphic adenoma (PA) has been extensively debated, mostly in relation to the extent of parotidectomy.

Methods: A systematic review was undertaken to clarify the surgical and pathological variables related to PA recurrence. Inclusion criteria were as follows: English literature, and prospective or retrospective studies. Exclusion criteria were as follows: single case reports, reviews, and lack of PA recurrence data.

Results: Pathology-related variables associated with recurrence include the histological subtype, the thickness and incompleteness of the tumor capsule, pseudopodia, and satellite nodules. Surgery-related variables associated with recurrence are the presence of intact margins and tumor puncture or spillage. Other factors are the size of the tumor and the age of patient. Myxoid subtypes of PA tend to have incomplete and thinner capsules and to recur more frequently. Surgical variables related to recurrence include positive margins and tumor spillage.

Conclusion: Myxoid and/or large PA, especially in young patients, should be approached more cautiously to avoid recurrences.

Citing Articles

Pleomorphic adenoma parotid surgery, how much margin we can reach to be safe?.

Mohebbi S, Zahedi M, Basir Shabestari S, Ahmadi A, Kazemipour S, Kadkhoda-Mohammadi M Dent Res J (Isfahan). 2025; 22:6.

PMID: 40028505 PMC: 11870331. DOI: 10.4103/drj.drj_336_24.

"Unraveling the Tapestry": A Retrospective Exploration of Recurrent Parotid Pleomorphic Adenoma Cases.

Sundarajan K, Subagar A, Arumugam K Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3227-3233.

PMID: 39130327 PMC: 11306486. DOI: 10.1007/s12070-024-04650-7.

Different MRI-based radiomics models for differentiating misdiagnosed or ambiguous pleomorphic adenoma and Warthin tumor of the parotid gland: a multicenter study.

Yang J, Bi Q, Jin Y, Yang Y, Du J, Zhang H Front Oncol. 2024; 14:1392343.

PMID: 38939335 PMC: 11208325. DOI: 10.3389/fonc.2024.1392343.

Evaluation of Salivary Function Post-Partial Superficial Parotidectomy.

Sepahi S, Aghaee A, Roshanzamir I, Ghorani-Azam A, Erfani S, Mashhadi L Iran J Otorhinolaryngol. 2024; 36(3):483-488.

PMID: 38745682 PMC: 11090091. DOI: 10.22038/IJORL.2024.76003.3551.

Correlation between MRI (DWI and DCE) and cellularity of parotid gland pleomorphic adenomas.

Monestier L, Del Grande J, Haddad R, Santini L, Michel J, Varoquaux A Eur Arch Otorhinolaryngol. 2024; 281(5):2655-2665.

PMID: 38498193 DOI: 10.1007/s00405-024-08562-8.

References

Cristofaro M, Allegra E, Giudice A, Colangeli W, Caruso D, Barca I . Pleomorphic adenoma of the parotid: extracapsular dissection compared with superficial parotidectomy--a 10-year retrospective cohort study. ScientificWorldJournal. 2014; 2014:564053. PMC: 4221864. DOI: 10.1155/2014/564053. View

Ghosh S, Panarese A, Bull P, Lee J . Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions. Clin Otolaryngol Allied Sci. 2003; 28(3):262-6. DOI: 10.1046/j.1365-2273.2003.00704.x. View

Huber A, Schmid S, Fisch U . [Pleomorphic adenoma of the parotid gland. Results of surgical treatment]. HNO. 1994; 42(9):553-8. View

Brieger J, Duesterhoeft A, Brochhausen C, Gosepath J, Kirkpatrick C, Mann W . Recurrence of pleomorphic adenoma of the parotid gland--predictive value of cadherin-11 and fascin. APMIS. 2009; 116(12):1050-7. DOI: 10.1111/j.1600-0463.2008.01088.x. View

Orita Y, Hamaya K, Miki K, Sugaya A, Hirai M, Nakai K . Satellite tumors surrounding primary pleomorphic adenomas of the parotid gland. Eur Arch Otorhinolaryngol. 2009; 267(5):801-6. DOI: 10.1007/s00405-009-1149-7. View

PATEY D, Thackray A . The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958; 45(193):477-87. DOI: 10.1002/bjs.18004519314. View

Laskawi R, Schott T, Schroder M . Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg. 1998; 36(1):48-51. DOI: 10.1016/s0266-4356(98)90748-3. View

Zbaren P, Vander Poorten V, Witt R, Woolgar J, Shaha A, Triantafyllou A . Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery?. Am J Surg. 2012; 205(1):109-18. DOI: 10.1016/j.amjsurg.2012.05.026. View

Guntinas-Lichius O, Klussmann J, Wittekindt C, Stennert E . Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope. 2006; 116(4):534-40. DOI: 10.1097/01.mlg.0000200741.37460.ea. View

10.

Abu-Ghanem Y, Mizrachi A, Popovtzer A, Abu-Ghanem N, Feinmesser R . Recurrent pleomorphic adenoma of the parotid gland: Institutional experience and review of the literature. J Surg Oncol. 2016; 114(6):714-718. DOI: 10.1002/jso.24392. View

11.

Laniukh S, KREMENETSKAIA L, Shipkova T . [Recurrence of polymorphic adenoma of the salivary glands]. Stomatologiia (Mosk). 1990; 69(2):40-3. View

12.

Takahashi M, Kumai M, Kamito T, Uehara M, Unno T . [Clinico-pathological findings of recurrent pleomorphic adenomas of the parotid gland]. Nihon Jibiinkoka Gakkai Kaiho. 1991; 94(4):489-94. DOI: 10.3950/jibiinkoka.94.489. View

13.

Stennert E, Guntinas-Lichius O, Klussmann J, Arnold G . Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases. Laryngoscope. 2002; 111(12):2195-200. DOI: 10.1097/00005537-200112000-00024. View

14.

Harney M, Murphy C, Hone S, Toner M, Timon C . A histological comparison of deep and superficial lobe pleomorphic adenomas of the parotid gland. Head Neck. 2003; 25(8):649-53. DOI: 10.1002/hed.10281. View

15.

Webb A, Eveson J . Pleomorphic adenomas of the major salivary glands: a study of the capsular form in relation to surgical management. Clin Otolaryngol Allied Sci. 2001; 26(2):134-42. DOI: 10.1046/j.1365-2273.2001.00440.x. View

16.

Xu Y, Li C, Fan J, Zhang B, Chen J, Wang Z . [Evidence for determining the safe surgical margin for pleomorphic adenoma of parotid gland]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012; 47(2):137-41. View

17.

Natvig K, Soberg R . Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study. Head Neck. 1994; 16(3):213-7. DOI: 10.1002/hed.2880160302. View

18.

Gentile R, Zeppa P, Zabatta A, Vetrani A . [The role of morphometry in the cytology of pleomorphic adenomas of the salivary glands]. Pathologica. 1994; 86(2):167-9. View

19.

Friedrich R, Li L, Knop J, Giese M, Schmelzle R . Pleomorphic adenoma of the salivary glands: analysis of 94 patients. Anticancer Res. 2005; 25(3A):1703-5. View

20.

Chilla R, Schneider K, Droese M . [Recurrence tendency and malignant transformation of pleomorphic adenomas]. HNO. 1986; 34(11):467-9. View